MicroRNA Childhood Cancer Catalog (M3Cs)

Publication Title	DOI	Year
MicroRNA-603 functions as an oncogene by suppressing BRCC2 protein translation in osteosarcoma	https://doi.org/10.3892/or.2016.4718	2016	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MicroRNA-761 targets FGFR1 to suppress the malignancy of osteosarcoma by deactivating PI3K/Akt pathway	https://doi.org/10.2147/OTT.S208263	2019	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
miR-885-5p suppresses osteosarcoma proliferation, migration and invasion through regulation of ?-catenin	https://doi.org/10.3892/ol.2018.9768	2019	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
SNHG16 promotes osteosarcoma progression and enhances cisplatin resistance by sponging miR-16 to upregulate ATG4B expression	https://doi.org/10.1016/j.bbrc.2019.08.019	2019	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MiR-100 Inhibits Osteosarcoma Cell Proliferation, Migration, and Invasion and Enhances Chemosensitivity by Targeting IGFIR	https://doi.org/10.1177/1533034615601281	2016	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MiR-200c regulates tumor growth and chemosensitivity to cisplatin in osteosarcoma by targeting AKT2	https://doi.org/10.1038/s41598-017-14088-3	2017	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
The tumor-suppressive microRNA-135b targets c-myc in osteoscarcoma	https://doi.org/10.1371/journal.pone.0102621	2014	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
miR-24 represses metastasis of human osteosarcoma cells by targeting Ack1 via AKT/MMPs pathway	https://doi.org/10.1016/j.bbrc.2017.02.045	2017	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
miR-18a-5p promotes cell invasion and migration of osteosarcoma by directly targeting IRF2	https://doi.org/10.3892/ol.2018.9032	2018	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MiR-26a inhibits stem cell-like phenotype and tumor growth of osteosarcoma by targeting Jagged1	https://doi.org/10.1038/onc.2016.194	2017	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
miR-624-5p promoted tumorigenesis and metastasis by suppressing hippo signaling through targeting PTPRB in osteosarcoma cells	https://doi.org/10.1186/s13046-019-1491-6	2019	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
miRNA-1284, a regulator of HMGB1, inhibits cell proliferation and migration in osteosarcoma	https://doi.org/10.1042/BSR20171675	2018	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
The TAZ-miR-224-SMAD4 axis promotes tumorigenesis in osteosarcoma	https://doi.org/10.1038/cddis.2016.468	2017	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
The effects of TRAF6 on proliferation, apoptosis and invasion in osteosarcoma are regulated by miR-124	https://doi.org/10.3892/ijmm.2018.3458	2018	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
miR-194 Suppresses Proliferation and Migration and Promotes Apoptosis of Osteosarcoma Cells by Targeting CDH2	https://doi.org/10.1159/000487973	2018	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
miR-181c associates with tumor relapse of high grade osteosarcoma	https://doi.org/10.18632/oncotarget.3539	2015	Cell line 1 Master/Detail View	Cell line and drug 3 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MiRNA-98-5p inhibits the progression of osteosarcoma by regulating cell cycle via targeting CDC25A expression	https://doi.org/10.26355/eurrev_201911_19542	2019	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Tumor-suppressing effects of miR-429 on human osteosarcoma	https://doi.org/10.1007/s12013-014-9885-8	2014	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
miR-210 promotes human osteosarcoma cell migration and invasion by targeting FGFRL1	https://doi.org/10.3892/ol.2018.8939	2018	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Overexpression of miR-1258 inhibits cell proliferation by targeting AKT3 in osteosarcoma	https://doi.org/10.1016/j.bbrc.2019.01.139	2019	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View

Publications